Skip Navigation LinksHome > March 2010 - Volume 26 - Issue 1 > Prolongation of QT Interval Induced by Electroconvulsive The...
Journal of ECT:
doi: 10.1097/YCT.0b013e3181a95d8c
Original Studies

Prolongation of QT Interval Induced by Electroconvulsive Therapy is Attenuated by Landiolol

Matsura, Masayo DDS*; Fujiwara, Yoshihiro MD†; Ito, Hiroshi MD†; Kandatsu, Nobuhisa MD†; Kato, Naoko DDS*; Harada, Jun MD*; Komatsu, Toru MD†

Collapse Box

Abstract

Objective: The objective of this study was to determine if landiolol, ultra short-acting β adrenoceptor antagonist, attenuates the prolongation of QT interval caused by electroconvulsive therapy (ECT).

Methods: Fifteen patients, scheduled to undergo ECT for the treatment of major depression disorder, were studied. In each patient, 2 sessions of ECT were picked up and randomly assigned to be administered with (treatment L) or without continuous infusion of landiolol (treatment C). Electroconvulsive therapy was administered under general anesthesia with propofol and suxamethonium. Raw electrocardiogram waves were obtained from anesthesia monitor and stored on a personal computer. Automated electrocardiogram analyzing software was used for the determination of QT interval.

Results: The increase in corrected QT caused by suxamethonium was significantly smaller in treatment L (36.8 ± 14.5 ms for treatment C vs 17.9 ± 6.5 ms for treatment L; P < 0.001). The increase in corrected QT caused by ECT was also smaller in treatment L (72.3 ± 23.1 ms for treatment C vs 54.6 ± 17.9 ms for treatment L; P = 0.02).

Conclusions: The prolongation of QT interval caused by SUX and ECT was partially attenuated by landiolol.

© 2010 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.